SAN DIEGO — Innovus Pharmaceuticals, Inc. announced that it has entered into a pilot program with the nationwide pharmaceutical chain CVS Pharmacy to sell the company’s product Androferti, to increase sperm quality. The CVS men’s health in-store clinic pilot program will promote Androferti in 12 to 20 stores.
If successful, the CVS pilot program could lead to the national pharmacy stocking and selling Androferti on a scalable level nationwide and could expand to add additional Innovus Pharma products.
“We are very pleased to have been chosen by CVS to be part of their newly established in-store men’s health clinic,” said Dr. Bassam Damaj, the president and chief executive officer of Innovus Pharma. “In addition, we are in discussion to potentially add more product under this program.”
